07 aug: Livigno uden ski…
16 aug: Flytning af pension til Luxembourg – valg af kapitalforvalter og ..
10-08-2012 18:55:00

J.P. Morgan Credit-Card Settlement Advances

Relateret indhold
Relateret debat
05 dec - 
En af de dyreste - men også sundeste banker i US...
05 dec - 
Har købt BAC i går. Fortryder det faktisk ..

--J.P. Morgan Chase agreed to pay $100 million

--Customers alleged company violated contracts by increasing minimum monthly payments

--Fairness hearing on settlement is set for Nov. 16

A federal judge has granted preliminary approval to a $100 million settlement of a class-action lawsuit alleging J.P. Morgan Chase & Co. (JPM) violated credit-card borrowers' contract terms by raising their minimum monthly payments.

The settlement, filed last month in U.S. District Court in San Francisco, would put to rest claims that the nation's largest bank by assets increased the amounts that certain customers were required to pay on their card-loan balances during the economic downturn.

Judge Maxine Chesney has set a fairness hearing on the settlement for Nov. 16, according to a court document filed Thursday.

A spokesman for J.P. Morgan declined to comment Friday.

A master class-action complaint filed in 2009 said the plaintiffs accepted offers from J.P. Morgan to transfer loan balances at other banks to J.P. Morgan credit-card accounts. The customers were offered fixed-rate, long-term loans, though J.P. Morgan later increased the minimum amount borrowers must pay on their accounts each month to 5% of their outstanding loan balance from 2%, according to the complaint, filed on behalf of about one million credit cardholders.

Borrowers who fail to make their minimum monthly payments typically pay late fees.

Reuters first reported news of the settlement receiving preliminary approval Friday.

The settlement is the latest card-related accord for J.P. Morgan, which along with numerous other large banks have been hit with lawsuits over overdraft policies and merchant transaction fees.

J.P. Morgan earlier this year agreed to pay $110 million to settle claims it reordered customers' debit-card transactions to generate additional overdraft fees. Bank of America Corp. (BAC), PNC Financial Services Group Inc. (PNC) and other banks have agreed to settle similar lawsuits.

Last month Visa Inc. (V), MasterCard Inc. (MA) and numerous banks that issue their credit cards, including J.P. Morgan, agreed to pay merchants $6.05 billion to settle allegations that they fixed the price of transaction fees retailers pay each time a customer swipes a card. J.P. Morgan's share of the settlement is $1.2 billion, the New York-based bank said in a regulatory filing Thursday.

That settlement is pending in federal court in Brooklyn.

J.P. Morgan is the second-largest U.S. credit card issuer based on purchase volume, according to the Nilson Report, a payments-industry newsletter.

J.P. Morgan's shares were down 0.4% at $36.77 in recent trading.

Write to Andrew R. Johnson at andrew.r.johnson@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 10, 2012 12:55 ET (16:55 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Aktier/tendens: Genmab og Vestas fortsætter i fokus
3
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
4
Vestas ejer mere end 5 pct. egne aktier efter opkøb
5
Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

Relaterede aktiekurser

Bank of America Corporat.. 29,22 -0,3% Fald i aktiekurs
JP Morgan Chase & Co 106,31 -0,5% Fald i aktiekurs
Visa Inc 113,51 0,0% Stigning i aktiekurs
Mastercard Incorporated 152,02 -0,3% Fald i aktiekurs
PNC Financial Services G.. 145,32 -0,4% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
13. december 2017 19:29:33
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB5 - 2017-12-13 19:29:33 - 2017-12-13 19:29:33 - 1 - Website: OKAY